weight loss injection retatrutide Retatrutide: The New Triple-Agonist Treatment How Does Retatrutide Make You

Retatrutide is an unlicensed triple agonist targeting GLP-1, GIP, and glucagon receptors, currently under clinical investigation for obesity and type 2 diabetes

No one should have to compromise their health or be subject to misinformation. To Hims & Hers, Sick of the System has pushed industry buttons exactly as intended

If your symptoms persist or become more intense, do not hesitate to speak with your healthcare provider

Standard Titration Protocol Treatment typically begins at 2mg weekly and increases gradually over several months

Treatment costs range from 325 to 440 weekly, or 1,300 to 1,760 monthly

Weight loss edge: tirzepatide The clinical evidence is now definitive tirzepatide produces greater average weight loss than semaglutide across trials and real-world data